搜尋結果
Four Star. Concise Prescribing Info. Contents. Alirocumab. Indications/Uses. Reduces risk of MI, stroke, & unstable angina requiring hospitalization in adults w/ established CV disease.
MIMS home. Drugs. Info. Levodropropizine. This information is not country-specific. Please refer to the Hong Kong prescribing information. Generic Medicine Info. Indications and Dosage. Oral. Cough. Adult: 60 mg up to tid at intervals of at least 6 hours.
MIMS home. Drugs. Info. Cosyr (Reformulated)咳敏消. Manufacturer: United Laboratories. Distributor: Unam. Concise Prescribing Info. Contents. Per 5 mL Dextromethorphan HBr 10 mg, chlorpheniramine maleate 1 mg. Indications/Uses. Cough in cold, flu, TB, bronchitis, bronchial asthma, pertussis, measles, pneumonia, excessive smoking, psychogenic cough.
MIMS home. Drugs. Info. Bronal. levodropropizine. Manufacturer: Eurodrug. Distributor: DCH Auriga - Healthcare. Concise Prescribing Info. Contents. Levodropropizine. Indications/Uses. Symptomatic treatment of cough in adult & childn >6 yr. Dosage/Direction for Use. Adult & childn >12 yr 10 mL tds, w/ at least 6-hr interval between doses.
SC Type 1 DM Once-daily w/ meal-time insulin & requires individual dose adjustments. Must be combined w/ short-/rapid-acting insulin to cover mealtime insulin requirements. Type 2 DM Initially 0.2 u/kg followed by individual dose adjustments. May also be given w/ other anti-hyperglycaemic products. Click to view Toujeo detailed prescribing ...
Info. Aklief. trifarotene. Concise Prescribing Info. Contents. Trifarotene. Indications/Uses. Cutaneous treatment of acne vulgaris of the face &/or the trunk in patients ≥12 yr, when many comedones, papules & pustules are present. Click to view Aklief detailed prescribing information. Dosage/Direction for Use.
Four Star. Concise Prescribing Info. Contents. Anastrozole. Indications/Uses. Adjuvant treatment of post-menopausal women w/ hormone receptor-positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive post-menopausal women who has received 2-3 yrs of adjuvant tamoxifen.
